Skip to main content
ORTIN GLOBAL LIMITED logo

ORTIN GLOBAL LIMITED — Investor Relations & Filings

Ticker · ORTINGLOBE ISIN · INE749B01020 BSE.NS Manufacturing
Open in API
Filings indexed 204 across all filing types
Latest filing 2025-09-05 Regulatory Filings
Country IN India
Listing BSE.NS ORTINGLOBE

About ORTIN GLOBAL LIMITED

https://www.ortinlabsindia.com/

Ortin Global Limited is a pharmaceutical enterprise engaged in the development, manufacture, and marketing of active pharmaceutical ingredients (APIs), intermediates, and finished dosage formulations. The company maintains a diverse product portfolio covering various therapeutic segments, such as anti-diabetics, anti-hypertensives, anti-retrovirals, analgesics, and anti-pyretics. Its operations include the synthesis of complex chemical molecules and the production of oral solids and liquids, including tablets, capsules, and syrups. With a focus on integrated manufacturing processes, the company serves both domestic and international healthcare markets. Ortin Global Limited prioritizes research and development to expand its product offerings and optimize production techniques, ensuring compliance with established quality standards across its manufacturing facilities.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a notification to stock exchanges about the outcome of a board meeting held on 05.09.2025. It states that the Board approved the 38th Directors Report for the financial year 2024-25 and the notice for convening the 38th Annual General Meeting (AGM). It also announces the date and mode of the AGM. The document is short (2014 characters) and serves as an announcement of decisions made at the board meeting rather than containing the full Directors Report or the AGM materials themselves. Therefore, it is not the Annual Report (10-K) or the AGM Information (AGM-R) but an official announcement of board meeting outcomes under SEBI regulations. This fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory announcements that do not contain the full report or detailed financial data.
2025-09-05 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an official filing to stock exchanges detailing the outcome of an Extraordinary General Meeting (EGM), including summary of proceedings, voting results, and scrutinizer report. This corresponds to Disclosure of Voting Results at a shareholder meeting. Hence it is a Declaration of Voting Results filing.
2025-08-25 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter dated 18.08.2025 from Ortin Global Limited addressed to stock exchanges (BSE and NSE) regarding the newspaper publication of the company's un-audited financial results for the quarter ended 30 June 2025. It references Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates the publication of financial results in newspapers. The document encloses copies of newspaper publications where the financial results are accessible via QR code and webpage link. The document itself does not contain the financial results or detailed financial statements but announces their publication and availability. The document length is 15,000 characters, but the content is primarily an announcement of the publication of the financial results, not the results themselves. According to the "Menu vs Meal" rule, such documents that announce the availability or publication of a report without containing the substantive financial data should be classified as Report Publication Announcement (RPA). Therefore, the appropriate classification is RPA with high confidence.
2025-08-18 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a stock exchange filing under SEBI LODR Regulations 2015 announcing and attaching the Board‐approved unaudited financial results for the quarter ended 30.06.2025, including full financial statements, notes, and a limited review report by auditors. This constitutes a substantive interim/quarterly financial report, not merely an earnings highlight or regulatory announcement. Hence, it falls under Interim / Quarterly Report (IR). Q1 2026
2025-08-14 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-08-07 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notice from Ortin Global Limited to stock exchanges about an upcoming Board Meeting scheduled for August 14, 2025. The purpose of the meeting includes consideration and approval of unaudited financial results for the quarter ended June 30, 2025, along with a limited review report. The document is an intimation or announcement of the meeting and the agenda, not the financial results or the report itself. The document length is short (1756 characters), and it serves as a notification rather than a report containing financial data. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about a board meeting and upcoming financial results, rather than an Interim Report (IR) or Earnings Release (ER).
2025-08-07 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.